Your search history is turned on.
Date: November 27, 2018 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
Microsoft Word - Vivione Biosciences - 2018 52-109FV2 (CEO) 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Tun Myo, Chief Executive Officer, Vivione Biosciences Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the interim filings) of Vivione...
Microsoft Word - Vivione Biosciences - 2018 52-109FV2 (CFO) 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Tun Myo, Chief Financial Officer, Vivione Biosciences Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the interim filings) of Vivione...
Microsoft Word - Vivione Biosciences - MDA_2018_Q3 MANAGEMENT DISCUSSION AND ANALYSIS For the three and nine month periods ended September 30, 2018 1 Vivione Biosciences Inc. This Management Discussion and Analysis (MD&A) for Vivione Biosciences Inc. (the Company or Vivione) should be read in conjunction with Viviones unaudited interim financial st...
Microsoft Word - Vivione Biosciences - September 30 2018 Financial statements Financial Statements Vivione Biosciences Inc. (Unaudited) For the three and nine month periods ended September 30, 2018 and 2017 2 NOTICE TO READER In accordance with National Instruments 51-102 released by the Canadian Securities ...
Date: August 31, 2018 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan
Microsoft Word - Vivione Biosciences - 2018 52-109FV2 (CEO) 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Tun Myo, Chief Executive Officer, Vivione Biosciences Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the interim filings) of Vivione Bioscience...
Microsoft Word - Vivione Biosciences - 2018 52-109FV2 (CFO) 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Tun Myo, Chief Financial Officer, Vivione Biosciences Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the interim filings) of Vivione Bioscience...
Microsoft Word - Vivione Biosciences - MDA_2018_Q2 MANAGEMENT DISCUSSION AND ANALYSIS For the three and six month periods ended June 30, 2018 1 Vivione Biosciences Inc. This Management Discussion and Analysis (MD&A) for Vivione Biosciences Inc. (the Company or Vivione) should be read in conjunction with Viviones unaudited interim financial statemen...
Microsoft Word - Vivione Biosciences - June 30 2018 Financial statements Financial Statements Vivione Biosciences Inc. (Unaudited) For the three and six month periods ended June 30, 2018 and 2017 2 NOTICE TO READER In accordance with National Instruments 51-102 released by the Canadian Securities Administra...
Date: May 28, 2018 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario, Saskatchewan